Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for epsilon-heavy chain disease has been reported in the published literature.
No clinical trials have been registered for epsilon-heavy chain disease.
15 publications have been identified in PubMed for epsilon-heavy chain disease. Research spans Basic Science / Preclinical (54%), Review / Meta-Analysis (23%), and Diagnostic / Biomarker (8%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 7 | 54% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
3 |
23% |
Testing and diagnosis research | 1 | 8% |
Patient case studies | 1 | 8% |
Disease patterns and progression | 1 | 8% |
Liu R (2026). [PMID: 41708235](https://pubmed.ncbi.nlm.nih.gov/41708235/). *Anal Chim Acta*. [Basic Science / Preclinical]
Hara R (2025). [PMID: 40046156](https://pubmed.ncbi.nlm.nih.gov/40046156/). *J Allergy Clin Immunol Glob*. [Basic Science / Preclinical]
Ugarte-Berzal E (2025). [PMID: 40785316](https://pubmed.ncbi.nlm.nih.gov/40785316/). *Allergy*. [Basic Science / Preclinical]
Liu YH (2025). [PMID: 40410722](https://pubmed.ncbi.nlm.nih.gov/40410722/). *Mol Med*. [Basic Science / Preclinical]
Li W (2025). [PMID: 40667723](https://pubmed.ncbi.nlm.nih.gov/40667723/). *FEBS Open Bio*. [Diagnostic / Biomarker]
Hanbali A (2025). [PMID: 40700098](https://pubmed.ncbi.nlm.nih.gov/40700098/). *Hematol Rep*. [Review / Meta-Analysis]
Suárez-Cuartín G (2025). [PMID: 41517428](https://pubmed.ncbi.nlm.nih.gov/41517428/). *J Clin Med*. [Review / Meta-Analysis]
Nair N (2025). [PMID: 40662763](https://pubmed.ncbi.nlm.nih.gov/40662763/). *J Clin Microbiol*. [Epidemiology / Natural History]
Luo WT (2025). [PMID: 40652585](https://pubmed.ncbi.nlm.nih.gov/40652585/). *Int Immunopharmacol*. [Basic Science / Preclinical]
Bhakta-Yadav MS (2024). [PMID: 38526216](https://pubmed.ncbi.nlm.nih.gov/38526216/). *Toxicol Sci*. [Basic Science / Preclinical]
AI-curated news mentioning epsilon-heavy chain disease
Updated Mar 19, 2026
A recent case report highlights novel laboratory approaches in diagnosing heavy chain disease, addressing challenges in immunoglobulin quantitation. This study contributes to the understanding of this rare condition and may inform future diagnostic strategies.